Approved Symbol |
Approved Name |
Location |
No. of Studies (Positive/Negative/Trend)  |
Evidence[PMID] |
HLA-A |
major histocompatibility complex, class I, A |
6p21.3 |
1(0/1/0)
|
IBA; IPI[19124746]
|
ADM |
adrenomedullin |
11p15.4 |
1(1/0/0)
|
TAS[8074714]
|
GDNF |
glial cell derived neurotrophic factor |
5p13.1-p12 |
1(1/0/0)
|
TAS[10829012]
|
ADCYAP1 |
adenylate cyclase activating polypeptide 1 (pituitary) |
18p11 |
3(1/2/0)
|
IPI[7680413]
|
SLC6A3 |
solute carrier family 6 (neurotransmitter transporter), member 3 |
5p15.3 |
11(5/6/0)
|
IEA
|
TENM2 |
teneurin transmembrane protein 2 |
5q35 |
1(0/0/1)
|
IDA[21724987]; IEA
|
CRH |
corticotropin releasing hormone |
8q13 |
2(1/1/0)
|
TAS[7477348]
|
NPPB |
natriuretic peptide B |
1p36.2 |
1(1/0/0)
|
IDA[1672777]; IPI[12727915]
|
HNF4A |
hepatocyte nuclear factor 4, alpha |
20q13.12 |
1(1/0/0)
|
IDA[12220494]
|
LGI1 |
leucine-rich, glioma inactivated 1 |
10q24 |
1(0/1/0)
|
IPI[20463223]; IPI[20463223]
|
LAMA3 |
laminin, alpha 3 |
18q11.2 |
1(0/0/1)
|
IEA
|
HLA-G |
major histocompatibility complex, class I, G |
6p21.3 |
1(1/0/0)
|
IPI[20702625]
|
DIAPH1 |
diaphanous-related formin 1 |
5q31 |
1(1/0/0)
|
NAS[9360932]
|
GJA1 |
gap junction protein, alpha 1, 43kDa |
6q22.31 |
1(1/0/0)
|
IEA
|
HLA-B |
major histocompatibility complex, class I, B |
6p21.3 |
2(0/1/1)
|
IBA; IPI[20008523]
|
NRXN1 |
neurexin 1 |
2p16.3 |
1(1/0/0)
|
ISS
|
ITK |
IL2-inducible T-cell kinase |
5q31-q32 |
1(1/0/0)
|
IBA
|
CXCL12 |
chemokine (C-X-C motif) ligand 12 |
10q11.1 |
1(0/0/1)
|
TAS[10358157]
|
GFRA1 |
GDNF family receptor alpha 1 |
10q25-q26 |
2(1/1/0)
|
TAS[9545641]
|
PTPRD |
protein tyrosine phosphatase, receptor type, D |
9p24.1-p23 |
1(0/0/1)
|
ISS
|
ANXA1 |
annexin A1 |
9q21.13 |
1(0/0/1)
|
TAS[10882119]
|
DDO |
D-aspartate oxidase |
6q22.1 |
1(1/0/0)
|
IPI[20178365]
|
P2RX4 |
purinergic receptor P2X, ligand gated ion channel, 4 |
12q24.32 |
1(0/1/0)
|
ISS[17785580]
|
CROT |
carnitine O-octanoyltransferase |
7q21.1 |
1(0/0/1)
|
IPI[20178365]
|
PLA2G1B |
phospholipase A2, group IB (pancreas) |
12q24.31 |
4(1/3/0)
|
IDA[1918029]; IPI[7721806]
|
CD276 |
CD276 molecule |
15q23-q24 |
1(0/1/0)
|
NAS[11224528]
|
ARRB2 |
arrestin, beta 2 |
17p13 |
1(1/0/0)
|
IPI[18604210]
|
UFD1L |
ubiquitin fusion degradation 1 like (yeast) |
22q11.2 |
1(0/1/0)
|
IEA
|
CHRNA10 |
cholinergic receptor, nicotinic, alpha 10 (neuronal) |
11p15.5 |
1(0/1/0)
|
TAS[11350119]
|
ITGB8 |
integrin, beta 8 |
7p15.3 |
1(1/0/0)
|
IEA
|
DAO |
D-amino-acid oxidase |
12q24.11 |
5(1/4/0)
|
IPI[20178365]
|
CCL2 |
chemokine (C-C motif) ligand 2 |
17q11.2-q21.1 |
3(1/2/0)
|
TAS[10542238]
|
PICK1 |
protein interacting with PRKCA 1 |
22q13.1 |
1(0/1/0)
|
ISS
|
NRG3 |
neuregulin 3 |
10q23.1 |
2(0/2/0)
|
IBA
|
TRIM24 |
tripartite motif containing 24 |
7q32-q34 |
1(1/0/0)
|
TAS[9115274]
|
P2RX7 |
purinergic receptor P2X, ligand gated ion channel, 7 |
12q24 |
9(2/7/0)
|
ISS[17785580]
|
NRG1 |
neuregulin 1 |
8p12 |
15(10/5/0)
|
IPI[7514177]
|